| EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent N Mottet, RCN van den Bergh, E Briers, T Van den Broeck, ... European urology 79 (2), 243-262, 2021 | 1995 | 2021 |
| EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ... European urology 79 (2), 263-282, 2021 | 781 | 2021 |
| A systematic review of the association between erectile dysfunction and cardiovascular disease G Gandaglia, A Briganti, G Jackson, RA Kloner, F Montorsi, P Montorsi, ... European urology 65 (5), 968-978, 2014 | 540 | 2014 |
| Distribution of metastatic sites in patients with prostate cancer: a population‐based analysis G Gandaglia, F Abdollah, J Schiffmann, V Trudeau, SF Shariat, SP Kim, ... The Prostate 74 (2), 210-216, 2014 | 498 | 2014 |
| Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer F Abdollah, RJ Karnes, N Suardi, C Cozzarini, G Gandaglia, N Fossati, ... J Clin Oncol 32 (35), 3939-3947, 2014 | 343 | 2014 |
| Impact of the site of metastases on survival in patients with metastatic prostate cancer G Gandaglia, PI Karakiewicz, A Briganti, NM Passoni, J Schiffmann, ... European urology 68 (2), 325-334, 2015 | 325 | 2015 |
| The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). G Gandaglia, A Briganti, P Gontero, N Mondaini, G Novara, A Salonia, ... BJU international 112 (4), 2013 | 309 | 2013 |
| Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis F Abdollah, G Gandaglia, R Thuret, J Schmitges, Z Tian, C Jeldres, ... Cancer epidemiology 37 (3), 219-225, 2013 | 293 | 2013 |
| Epidemiology and prevention of prostate cancer G Gandaglia, R Leni, F Bray, N Fleshner, SJ Freedland, A Kibel, P Stattin, ... European urology oncology 4 (6), 877-892, 2021 | 281 | 2021 |
| Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years N Suardi, G Gandaglia, A Gallina, E Di Trapani, V Scattoni, D Vizziello, ... European urology 67 (2), 299-309, 2015 | 276 | 2015 |
| Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies A Necchi, D Raggi, A Gallina, R Madison, M Colecchia, R Luciano, ... European urology 77 (4), 439-446, 2020 | 261 | 2020 |
| A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance … G Gandaglia, G Ploussard, M Valerio, A Mattei, C Fiori, N Fossati, ... European urology 75 (3), 506-514, 2019 | 240 | 2019 |
| More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer F Abdollah, G Gandaglia, N Suardi, U Capitanio, A Salonia, A Nini, ... European urology 67 (2), 212-219, 2015 | 233 | 2015 |
| Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era G Gandaglia, JD Sammon, SL Chang, TK Choueiri, JC Hu, PI Karakiewicz, ... Journal of Clinical Oncology 32 (14), 1419-1426, 2014 | 233 | 2014 |
| Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study S Joniau, A Briganti, P Gontero, G Gandaglia, L Tosco, S Fieuws, ... European urology 67 (1), 157-164, 2015 | 214 | 2015 |
| EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international … TBL Lam, S MacLennan, PPM Willemse, MD Mason, K Plass, R Shepherd, ... European urology 76 (6), 790-813, 2019 | 211 | 2019 |
| Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer G Gandaglia, N Fossati, E Zaffuto, M Bandini, P Dell’Oglio, CA Bravi, ... European urology 72 (4), 632-640, 2017 | 210 | 2017 |
| Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy A Briganti, RJ Karnes, S Joniau, SA Boorjian, C Cozzarini, G Gandaglia, ... European urology 66 (3), 479-486, 2014 | 162 | 2014 |
| Benefits and risks of primary treatments for high-risk localized and locally advanced prostate cancer: an international multidisciplinary systematic review L Moris, MG Cumberbatch, T Van den Broeck, G Gandaglia, N Fossati, ... European urology 77 (5), 614-627, 2020 | 142 | 2020 |
| Impact of molecular subtyping and immune infiltration on pathological response and outcome following neoadjuvant pembrolizumab in muscle-invasive bladder cancer A Necchi, D Raggi, A Gallina, JS Ross, E Farè, P Giannatempo, ... European urology 77 (6), 701-710, 2020 | 141 | 2020 |
